Key points from article :
A group of independent biologists plan on creating a knock-off of a costly gene therapy.
Glybera is used to treat a very rare inherited disease known as lipoprotein lipase deficiency.
Biohackers produced Slybera a copy-cat drug which is much less costly.
Uses a circular genetic construct called "minicircle" instead of using viruses as Glybera did.
Plans to test Slybera on animals first.
